NeuroBo Pharmaceuticals, Inc. (NRBO)
NASDAQ: NRBO · IEX Real-Time Price · USD
4.340
+0.040 (0.93%)
At close: Mar 27, 2024, 4:00 PM
4.400
+0.060 (1.38%)
After-hours: Mar 27, 2024, 4:12 PM EDT

NeuroBo Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202220212020201920182017201620152014
Selling, General & Admin
8.648.757.852.71.6110.445.963.180.21
Research & Development
2.786.554.535.325.0722.698.743.990.05
Other Operating Expenses
8.21017.3412.158.820.0100.910
Operating Expenses
19.6315.329.7220.1815.4933.1314.78.080.27
Operating Income
-19.63-15.3-29.72-20.18-15.49-33.13-14.7-8.08-0.27
Interest Expense / Income
2.19000.020.040.29-0.110.760.06
Other Expense / Income
-7.85-0.01-0.041.110--0.19-0
Pretax Income
-13.97-15.28-29.68-21.31-15.53-33.42-14.59-9.03-0.32
Net Income
-13.97-15.28-29.68-21.31-15.53-33.42-14.59-9.03-0.32
Preferred Dividends
0000000.374.020
Net Income Common
-13.97-15.28-29.68-21.31-15.53-33.42-14.95-13.04-0.32
Shares Outstanding (Basic)
000000000
Shares Outstanding (Diluted)
000000000
Shares Change
233.62%42.72%210.43%22.88%926.78%78.20%102.09%88.58%-
EPS (Basic)
-43.44-158.48-439.24-979.30-876.09-19381.94-15421.54-27242.72-1260.13
EPS (Diluted)
-43.44-158.48-439.24-979.30-876.09-19381.94-15421.54-27242.72-1260.13
Free Cash Flow
-11.7-15.14-10.77-7.25-14.45-26.9-11.04-5.43-0.2
Free Cash Flow Per Share
-36.38-156.98-159.37-333.24-816.05-15597.64-11406.45-11339.35-768.95
EBITDA
-11.75-15.21-29.61-21.27-15.49-33.13-14.7-8.27-0.27
Depreciation & Amortization
0.030.070.070.0200000
EBIT
-11.78-15.28-29.68-21.29-15.49-33.13-14.7-8.27-0.27
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).